GeneNews (GEN) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period GeneNews: Q1 Earnings SnapshotMay 16, 2024 | washingtonpost.comVertex, Crispr Get Second FDA Approval for Gene TherapyJanuary 18, 2024 | msn.comGene-editing treatment from Vertex and CRISPR cleared for second rare blood disorderJanuary 17, 2024 | msn.comFDA expands use of newly approved CRISPR therapyJanuary 17, 2024 | msn.comOhio St hires Texas A&M athletic director Ross Bjork to replace the retiring Gene SmithJanuary 16, 2024 | washingtonpost.comMutated gene thought to exist in just 4% of people could ‘help tackle obesity’November 27, 2023 | msn.comSickle-Cell Treatment Created With Gene Editing Wins U.K. ApprovalNovember 18, 2023 | nytimes.comUK authorizes gene therapy for blood disorders in world firstNovember 17, 2023 | msn.comMac Jones Losing Support of Patriots Teammates After Being Benched for Third Time, ReportNovember 16, 2023 | msn.comGene Frenette: Mac Jones' decline with Patriots also a product of Bill Belichick negligenceNovember 16, 2023 | usatoday.comSarepta Seeks Broader Approval for Gene Therapy Even After Drug Trial FizzledOctober 31, 2023 | msn.comSarepta Therapeutics Stock Dives After New Gene Therapy DataOctober 31, 2023 | wsj.comFDA panel considers gene therapy as a potential cure for the sickest sickle cell patientsOctober 31, 2023 | msn.comOncology Molecular Diagnostics Market by 2031March 27, 2023 | marketwatch.comGlobal Colorectal Cancer Diagnostic Market Industry Insights, Drivers, Top Trends, Global Analysis, Forecast and Opportunities to 2030 By VMReportsMarch 19, 2023 | marketwatch.comBiotech Stock Mailbag: GenVecJanuary 5, 2023 | thestreet.comStageZero Life Sciences Ltd (SZLS)February 23, 2022 | investing.com Get GeneNews News Delivered to You Automatically Sign up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter. Email Address GEN Media Mentions By Week GEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GEN News Sentiment▼0.000.64▲Average Medical News Sentiment GEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GEN Articles This Week▼00▲GEN Articles Average Week Get GeneNews News Delivered to You Automatically Sign up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sherritt International News Japan Gold News Cantex Mine Development News Innovotech News Rocky Mountain Liquor News Shopify News Constellation Software News Saputo News Lightspeed Commerce News Vanguard FTSE Canadian High Dividend Yield Index ETF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:GEN) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredInvesting Tools You’ll Need for 2025Investing Tools You’ll Need for 2025 Charles Payne Shares His #1 Strategy for 2025 Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneNews Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneNews With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
